JP2004522741A5 - - Google Patents

Download PDF

Info

Publication number
JP2004522741A5
JP2004522741A5 JP2002559011A JP2002559011A JP2004522741A5 JP 2004522741 A5 JP2004522741 A5 JP 2004522741A5 JP 2002559011 A JP2002559011 A JP 2002559011A JP 2002559011 A JP2002559011 A JP 2002559011A JP 2004522741 A5 JP2004522741 A5 JP 2004522741A5
Authority
JP
Japan
Prior art keywords
active ingredient
film
formulation
composition
pharmacologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002559011A
Other languages
English (en)
Japanese (ja)
Other versions
JP4303471B2 (ja
JP2004522741A (ja
Filing date
Publication date
Priority claimed from SE0100200A external-priority patent/SE0100200D0/xx
Application filed filed Critical
Publication of JP2004522741A publication Critical patent/JP2004522741A/ja
Publication of JP2004522741A5 publication Critical patent/JP2004522741A5/ja
Application granted granted Critical
Publication of JP4303471B2 publication Critical patent/JP4303471B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002559011A 2001-01-24 2002-01-22 新規フィルム・コーティング Expired - Fee Related JP4303471B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100200A SE0100200D0 (sv) 2001-01-24 2001-01-24 New film coating
PCT/SE2002/000103 WO2002058677A1 (en) 2001-01-24 2002-01-22 New film coating

Publications (3)

Publication Number Publication Date
JP2004522741A JP2004522741A (ja) 2004-07-29
JP2004522741A5 true JP2004522741A5 (enExample) 2005-12-22
JP4303471B2 JP4303471B2 (ja) 2009-07-29

Family

ID=20282714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002559011A Expired - Fee Related JP4303471B2 (ja) 2001-01-24 2002-01-22 新規フィルム・コーティング

Country Status (21)

Country Link
US (1) US7959947B2 (enExample)
EP (1) EP1355635B1 (enExample)
JP (1) JP4303471B2 (enExample)
KR (1) KR100874582B1 (enExample)
CN (1) CN1218692C (enExample)
AT (1) ATE285229T1 (enExample)
AU (1) AU2002225573B2 (enExample)
BR (1) BR0206515A (enExample)
CA (1) CA2433530A1 (enExample)
DE (2) DE60202351T2 (enExample)
DK (1) DK1355635T3 (enExample)
ES (1) ES2233804T3 (enExample)
IL (2) IL156623A0 (enExample)
MX (1) MXPA03006419A (enExample)
NO (1) NO20033305L (enExample)
NZ (1) NZ526792A (enExample)
PT (1) PT1355635E (enExample)
SE (1) SE0100200D0 (enExample)
SI (1) SI1355635T1 (enExample)
WO (1) WO2002058677A1 (enExample)
ZA (1) ZA200305457B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1355633B1 (en) * 2001-12-19 2005-01-19 AstraZeneca AB NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
ES2377729T3 (es) * 2002-02-21 2012-03-30 Valeant International (Barbados) Srl Formulaciones de liberación modificada de al menos una forma de tramadol
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating
AU2003282375A1 (en) * 2003-02-05 2004-08-30 Ipca Laboratories Limited Pharmaceutical compositions and process of production thereof
RU2372893C2 (ru) * 2003-10-31 2009-11-20 Хексал Аг Содержащий фармацевтический агент состав с покрытием
GB0403098D0 (en) 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
TWI350762B (en) 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
DE14172396T1 (de) 2004-10-08 2015-01-08 Forward Pharma A/S Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester
CN102369000A (zh) * 2009-01-09 2012-03-07 前进制药公司 包含一种或多种富马酸酯的药用组合物
CN109044985A (zh) 2009-01-09 2018-12-21 前进制药知识产权有限公司 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
US20110229564A1 (en) * 2010-03-22 2011-09-22 Amneal Pharmaceuticals, L.L.C. Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof
EP2844296B1 (en) * 2012-05-02 2019-03-13 Capsugel Belgium NV Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
MX2015010449A (es) 2013-02-13 2015-10-30 Evonik Roehm Gmbh Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos.
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
CN105085778B (zh) * 2014-04-22 2018-11-16 广东华润涂料有限公司 用于缓释功能成分的涂料组合物用水性胶乳、其制备方法以及应用
RS62275B1 (sr) * 2015-03-03 2021-09-30 Saniona As Kombinovana formulacija tesofensina i metoprolola
MA45553A (fr) * 2016-06-30 2019-05-08 Beckman Coulter Inc Substrats chimioluminescents
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB878234A (en) 1958-12-18 1961-09-27 Roehm & Haas Gmbh Pharmaceutical coating compositions
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) * 1965-05-28 1967-09-12 Union Carbide Corp Polysiloxane polish formulations
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4916171A (en) * 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US5246714A (en) * 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4975283A (en) * 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
EP0313845A1 (en) 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
FR2655266B1 (fr) 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.
JP2558396B2 (ja) 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5656296A (en) * 1992-04-29 1997-08-12 Warner-Lambert Company Dual control sustained release drug delivery systems and methods for preparing same
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1355633B1 (en) * 2001-12-19 2005-01-19 AstraZeneca AB NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating

Similar Documents

Publication Publication Date Title
JP2004522741A5 (enExample)
CN103517708B (zh) 药物组合物
AU781707B2 (en) Oral pharmaceutical forms of administration with a delayed action
JP2009545560A5 (enExample)
CA2651716A1 (en) Duloxetine hydrochloride delayed release formulations
JP2009530298A5 (enExample)
RU2003125371A (ru) Новое пленочное покрытие
JP2005526043A5 (enExample)
RU2372893C2 (ru) Содержащий фармацевтический агент состав с покрытием
CA2882544C (en) Medicament-containing hollow particle
JPH05201856A (ja) アクリルポリマーコーティングを有する高安定性放出制御型薬剤及びその製法
JP2006514988A5 (enExample)
JPH0710773B2 (ja) 一定の放出性及び即時放出性を有する薬物粒子
CN1674873A (zh) 药物组合物
US12370144B2 (en) Centanafadine pharmaceutical formulations, and methods of making and using same
CN109310642A (zh) 美沙拉嗪的口服药物组合物
CA2697437A1 (en) Pharmaceutical combination of aliskiren and valsartan
AU2004315136B2 (en) Extended release coated microtablets of venlafaxine hydrochloride
KR20060132891A (ko) 다중미립자 ｏ－데스메틸벤라팍신 염 및 그의 용도
US6238703B1 (en) Controlled release oral dosage form of ketoprofen
JP2005538117A5 (enExample)
US9333175B2 (en) Controlled release levetiracetam formulations and methods for producing the same
ES2377473B1 (es) Pellets entéricos de duloxetina.
CN101965181A (zh) 择时释放制剂
CN102429892A (zh) 左旋硫酸沙丁胺醇脉冲胶囊及其制备方法